1. Others
  2. Others
  3. Anticancer agent 31

Anticancer agent 31 

Cat. No.: HY-143302
Handling Instructions

Anticancer agent 31 is a 1,3-diphenylurea quinoxaline derivative, and a anticancer agent. Anticancer agent 31 exhibits antitumor acitvity by arresting cell cycle at S phase and inducing apoptosis.

For research use only. We do not sell to patients.

Anticancer agent 31 Chemical Structure

Anticancer agent 31 Chemical Structure

CAS No. : 2222930-72-3

Size Stock
100 mg   Get quote  
250 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Anticancer agent 31 is a 1,3-diphenylurea quinoxaline derivative, and a anticancer agent. Anticancer agent 31 exhibits antitumor acitvity by arresting cell cycle at S phase and inducing apoptosis[1].

In Vitro

Anticancer agent 31 (compound 2d) shows anticancer activity against human tumor cell lines (MGC-803, NCI-H460, T-24, HeLa, HepG2, and SMMC-7721) and displays lower cytotoxicity than 5-FU (HY-90006), Sorafenib (HY-10201), and Cisplatin (HY-17394)[1].
Anticancer agent 31 (10, and 15 μM; 24 h) arrests cell cycle at S phase in MGC-803 cells, and induces tumor cells apoptosis[1].
Anticancer agent 31 (5, 10, and 15 μM; 24 h) reduces cell cycle regulatory protein CDK2, CDK4, cyclin A2, cyclin B1, and Apaf-1, anti-apoptotic protein Bcl-2; increases pro-apoptotic protein Bax protein level[1].
Anticancer agent 31 (5, 10 μM; 24 h) activates caspase-3 and caspase-9 by 73.6% and 65.3%, respectively; and also causes the loss of mitochondrial membrane potential (MMP) increase in JC-1 (HY-15534) detection[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cytotoxicity Assay[1]

Cell Line: Normal cell line: HL-7702 and six human tumor cell lines: MGC-803, NCI-H460, T-24, HeLa, HepG2, and SMMC-7721
Concentration:
Incubation Time:
Result: Inhibited human tumor cell with IC50s of 9 μM (MGC-803), 12.3 μM (HeLa), 13.3 μM (NCI-H460), 30.4 μM (HepG2), 17.6 μM (SMMC-7721), 27.5 μM (T-24), respectively. Showed lowe cytotoxicity with an IC50 value of 80.9 μM, higher than the IC50s of tumor cell cells.

Western Blot Analysis[1]

Cell Line: MGC-803
Concentration: 0, 5, 10, 15 μM
Incubation Time: 24 hours
Result: Decreased cell cycle regulatory protein (cyclin-dependent kinase (CDK)2, CDK4, cyclin A2, and cyclin B1) levels in a dose-dependent manner.
Suppressed anti-apoptotic protein Bcl-2 expression and up-regulated pro-apoptotic protein Bax level.

Apoptosis Analysis[1]

Cell Line: MGC-803
Concentration: 0, 5, 10, 15 μM
Incubation Time: 24 hours
Result: Caused MGC-803 cells arrest at S phase from 24.45% to 41.39% at 15 μM concentration.
Indicated that there was a interaction with DNA in the nucleus and affect DNA replication.
Increased the percentage of apoptotic tumor cells from 4.31% to 37.21%.

Immunofluorescence[1]

Cell Line: MGC-803
Concentration: 5, 10 μM
Incubation Time: 24 hours; JC-1 as the fluorescent probe
Result: Induced the loss of mitochondrial membrane potential (MMP) from 0.79% (control) to 37.4% (5 μM) and 81.4% (10 μM), respectively.
Molecular Weight

497.50

Formula

C28H21F2N5O2

CAS No.
SMILES

O=C(NC1=CC=CC(CNC2=NC3=CC(F)=C(C=C3N=C2)F)=C1)NC4=CC=C(C=C4)OC5=CC=CC=C5

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email address *

Phone number *

 

Organization name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Anticancer agent 31
Cat. No.:
HY-143302
Quantity:
MCE Japan Authorized Agent: